Previous Close | 15.65 |
Open | 15.69 |
Bid | 15.25 x 1000 |
Ask | 16.48 x 900 |
Day's Range | 15.43 - 15.72 |
52 Week Range | 13.16 - 17.85 |
Volume | |
Avg. Volume | 582,333 |
Market Cap | 5.51B |
Beta (5Y Monthly) | 0.46 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.29 |
Earnings Date | Jul 31, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 27.19 |
From what we can see, insiders were net buyers in Bausch + Lomb Corporation's ( NYSE:BLCO ) during the past 12 months...
The transaction was filed with the SEC and indicates a strong signal of confidence from the insider. Following this acquisition, the insider now owns 627,419 shares of Bausch & Lomb Corp. Bausch & Lomb Corp is primarily engaged in the development, manufacture, and marketing of a range of pharmaceutical, medical device, and over-the-counter products, particularly in eye health.
Announced its second-quarter 2024 financial results. Total reported revenue was $1.216 billion for the ...